Ministry of Health's injection regulation and collagen debates
Following the Ministry of Health's decision to prevent the external procurement of intra-articular injections, new allegations regarding collagen products are coming to the forefront in the sector.
Following the Ministry of Health's regulation that prevents patients from obtaining intra-articular injection products externally with a prescription, collagen injections have become a subject of debate in the healthcare sector.
Intra-articular injection regulation and targeted objectives
The regulation introduced by the Ministry of Health regarding the procurement and application of intra-articular injections in public hospitals has initiated an important transformation process in the sector.
By replacing external product purchases by patients with procurement through hospitals and the central supply system, it aims to strengthen patient safety and public oversight.
Allegations from the field and the orientation toward collagen injection
Immediately after the regulation was implemented, certain allegations coming from the field sparked a new debate in the medical world and brought the issue to the center of the agenda.
It is claimed that some physicians and healthcare institutions have started directing patients toward collagen-containing injections instead of products available in the current supply system.
Experts' warnings on scientific rationale and supply methods
Sector representatives state that the real issue to be discussed is not collagen itself, but rather the indication and scientific rationale with which the product is used.
According to experts, a different product name should by no means constitute a justification for circumventing the purpose of the supply and control mechanisms established in public hospitals.
Marketing activities and allegations of new loopholes
One of the most significant criticisms voiced in the sector is that, following the regulation, certain companies have begun marketing collagen injections much more intensively.
This situation has brought up the question in the public eye of whether collagen products are being used as a new loophole in intra-articular injections.
Public authority's control mechanism and traceability
It is of vital importance to protect the system established by the public authority to protect the patient and ensure the traceability of products.
It is emphasized that this regulation, introduced to prevent uncontrolled external product procurement, must not be rendered ineffective through different product names.